Anakinra treatment for refractory cerebral autoinflammatory responses
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51500
Abstract: Refractory cerebral autoinflammatoryâautoimmune diseases are often associated with dysregulated innate immunity and are targeted by anakinra, an interleukinâ1 receptor antagonist. We analyzed the therapeutic effect of anakinra in refractory cerebral autoinflammatory response (CAIR) at a… read more here.
Keywords: autoinflammatory responses; anakinra treatment; refractory cerebral; cerebral autoinflammatory ... See more keywords